These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
695 related items for PubMed ID: 10643176
1. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results. Tindall E. J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176 [Abstract] [Full Text] [Related]
2. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect? Geis GS. Scand J Rheumatol Suppl; 1999 Nov; 109():31-7. PubMed ID: 10422544 [Abstract] [Full Text] [Related]
3. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect? Geis GS. J Rheumatol Suppl; 1999 Apr; 56():31-6. PubMed ID: 10225538 [Abstract] [Full Text] [Related]
4. Celecoxib, a COX-2--specific inhibitor: the clinical data. Fort J. Am J Orthop (Belle Mead NJ); 1999 Mar; 28(3 Suppl):13-8. PubMed ID: 10193998 [Abstract] [Full Text] [Related]
5. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis. Hochberg MC. Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069 [Abstract] [Full Text] [Related]
6. Pain management in osteoarthritis: the role of COX-2 inhibitors. Lane NE. J Rheumatol Suppl; 1997 Jul; 49():20-4. PubMed ID: 9249647 [Abstract] [Full Text] [Related]
7. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice. Wolfe F, Michaud K, Burke TA, Zhao SZ. J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808 [Abstract] [Full Text] [Related]
8. Antiinflammatory and analgesic efficacy of COX-2 specific inhibition: from investigational trials to clinical experience. Bensen WG. J Rheumatol Suppl; 2000 Oct; 60():17-24. PubMed ID: 11032098 [Abstract] [Full Text] [Related]
9. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo. Bensen WG, Zhao SZ, Burke TA, Zabinski RA, Makuch RW, Maurath CJ, Agrawal NM, Geis GS. J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327 [Abstract] [Full Text] [Related]
10. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA. Cancer Res; 2000 Sep 15; 60(18):5040-4. PubMed ID: 11016626 [Abstract] [Full Text] [Related]
11. COX-2 inhibitors. Brooks PM, Day RO. Med J Aust; 2000 Oct 16; 173(8):433-6. PubMed ID: 11090038 [Abstract] [Full Text] [Related]
12. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results]. Oliw E, Wollheim FA. Lakartidningen; 2000 Jun 14; 97(24):2942-4. PubMed ID: 10900877 [No Abstract] [Full Text] [Related]
13. [COX-2 inhibitor non-steroidal anti-inflammatory drugs, myth or reality?]. Peretz A. Rev Med Brux; 2001 Sep 14; 22(4):A377-80. PubMed ID: 11680204 [Abstract] [Full Text] [Related]
14. COX-2 inhibitors: new drugs for the management of pain and inflammation. Hutchins V, Hutchins B. Dent Today; 2001 Feb 14; 20(2):56-61. PubMed ID: 12524847 [No Abstract] [Full Text] [Related]
15. [Specific COX-2 inhibitors: prospects of therapy with new analgesic and anti-inflammatory substances]. Hinz B, Brune K. Wien Klin Wochenschr; 1999 Feb 12; 111(3):103-12. PubMed ID: 10093892 [Abstract] [Full Text] [Related]
16. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention. Kismet K, Akay MT, Abbasoglu O, Ercan A. Cancer Detect Prev; 2004 Feb 12; 28(2):127-42. PubMed ID: 15068837 [Abstract] [Full Text] [Related]
17. Outcome of specific COX-2 inhibition in rheumatoid arthritis. Lipsky PE, Isakson PC. J Rheumatol Suppl; 1997 Jul 12; 49():9-14. PubMed ID: 9249645 [Abstract] [Full Text] [Related]
18. Celecoxib: a COX-2 inhibitor. Andrews SA, Wallace CK, Davis RL. Am J Manag Care; 1999 Apr 12; 5(4):511-8; quiz 522-4. PubMed ID: 10387389 [No Abstract] [Full Text] [Related]
19. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Simon LS, Lanza FL, Lipsky PE, Hubbard RC, Talwalker S, Schwartz BD, Isakson PC, Geis GS. Arthritis Rheum; 1998 Sep 12; 41(9):1591-602. PubMed ID: 9751091 [Abstract] [Full Text] [Related]
20. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM, Hubbard RC, Isakson PC, Verburg KM, Geis GS. Mayo Clin Proc; 1999 Nov 12; 74(11):1095-105. PubMed ID: 10560596 [Abstract] [Full Text] [Related] Page: [Next] [New Search]